Intraarterial Administration of Bone Marrow Mononuclear Cells in Patients With Critical Limb Ischemia

@inproceedings{Walter2011IntraarterialAO,
  title={Intraarterial Administration of Bone Marrow Mononuclear Cells in Patients With Critical Limb Ischemia},
  author={Dirk Walter and Hans Krankenberg and J{\"o}rn Oliver Balzer and Christoph Kalka and Iris Baumgartner and Michael Schl{\"u}ter and Torsten Tonn and Florian Hartmut Seeger and Stefanie Dimmeler and Edelgard Lindhoff-Last and Andreas Michael Zeiher},
  year={2011}
}
Background—Critical limb ischemia due to peripheral arterial occlusive disease is associated with a severely increased morbidity and mortality. There is no effective pharmacological therapy available. Injection of autologous bone marrow-derived mononuclear cells (BM-MNC) is a promising therapeutic option in patients with critical limb ischemia, but double-blind, randomized trials are lacking. Methods and Results—Forty patients with critical limb ischemia were included in a multicenter, phase II… CONTINUE READING